US consumers tell FDA: VNS (vagus nerve stimulation) depression device "not convincing"
This article was originally published in Clinica
Executive Summary
The US consumer group Public Citizen has urged the FDA not to proceed with its imminent approval of Cyberonics' vagus nerve stimulation (VNS) therapy for depression.